Allianz Asset Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-63,744
| Closed | -$1.28M | – | 2245 |
|
2018
Q3 | $1.28M | Buy |
63,744
+8,507
| +15% | +$170K | ﹤0.01% | 1699 |
|
2018
Q2 | $1.43M | Sell |
55,237
-357
| -0.6% | -$9.22K | ﹤0.01% | 1629 |
|
2018
Q1 | $1.33M | Buy |
55,594
+2,513
| +5% | +$60.1K | ﹤0.01% | 1634 |
|
2017
Q4 | $1.8M | Sell |
53,081
-929
| -2% | -$31.5K | ﹤0.01% | 1570 |
|
2017
Q3 | $1.14M | Sell |
54,010
-331
| -0.6% | -$7.01K | ﹤0.01% | 1663 |
|
2017
Q2 | $950K | Sell |
54,341
-1,139
| -2% | -$19.9K | ﹤0.01% | 1707 |
|
2017
Q1 | $971K | Buy |
55,480
+30,952
| +126% | +$542K | ﹤0.01% | 1730 |
|
2016
Q4 | $415K | Sell |
24,528
-6,031
| -20% | -$102K | ﹤0.01% | 1863 |
|
2016
Q3 | $501K | Sell |
30,559
-5,917
| -16% | -$97K | ﹤0.01% | 1821 |
|
2016
Q2 | $552K | Buy |
+36,476
| New | +$552K | ﹤0.01% | 1750 |
|